Elevance Health, Inc.

Connor, Clark & Lunn Investment Management Ltd. ELV

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/12/2026

Shares

13,203

Value ($000)

5,106

Weight

0.0%

2019 Q4 - 2026 Q2 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/12/2026	5,106	0.0%	13,203	6/30/2026
2025 Q2	8/7/2025	609	0.0%	1,565	6/30/2025
2025 Q1	5/12/2025	2,116	0.0%	4,864	3/31/2025
2024 Q3	11/8/2024	2,560	0.0%	4,923	9/30/2024
2024 Q2	8/9/2024	476	0.0%	879	6/30/2024
2024 Q1	5/9/2024	1,170	0.0%	2,257	3/31/2024
2023 Q4	2/9/2024	11,853	0.1%	25,135	12/31/2023
2023 Q3	11/13/2023	2,487	0.0%	5,711	9/30/2023
2023 Q2	8/10/2023	7,661	0.0%	17,243	6/30/2023
2022 Q4	2/10/2023	29,278	0.2%	57,075	12/31/2022
2022 Q3	11/10/2022	16,247	0.1%	35,768	9/30/2022
2022 Q2	8/5/2022	15,804	0.1%	32,748	6/30/2022
2022 Q1	5/12/2022	24,943	0.1%	50,778	3/31/2022
2021 Q4	2/10/2022	33,774	0.2%	72,862	12/31/2021
2021 Q3	11/12/2021	12,551	0.1%	33,667	9/30/2021
2021 Q2	8/12/2021	6,881	0.0%	18,023	6/30/2021
2021 Q1	5/13/2021	11,387	0.1%	31,724	3/31/2021
2020 Q3	11/12/2020	10,586	0.1%	39,413	9/30/2020
2020 Q2	8/13/2020	9,128	0.1%	34,710	6/30/2020
2020 Q1	5/13/2020	420	0.0%	1,850	3/31/2020
2019 Q4	2/12/2020	4,734	0.0%	15,675	12/31/2019